Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EXOSC10 antisense RNA 1 (EXOSC10-AS1) is a long noncoding RNA transcribed in the antisense direction relative to the EXOSC10 gene[2][6][8]. There is currently very limited functional information about EXOSC10-AS1 in the published literature or major gene/protein databases. No evidence supports its direct role as a therapeutic target, biomarker, or disease gene. Like other antisense lncRNAs, it may exert gene expression regulatory functions, potentially modulating EXOSC10 mRNA stability or transcription, but no specific biological functions have been experimentally validated or assigned in curated reference sources as of mid-2025[6][8][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EXOSC10 antisense RNA 1 (EXOSC10-AS1).